Terveystalo account plan
Health care services in Finland
At a glance
Terveystalo is Finland's largest private healthcare provider by revenue, with EUR 1,278.9 million FY2025 revenue and around 14,400 professionals.
Terveystalo provides primary care, specialised care, diagnostics, dental and wellbeing services in Finland to corporate clients, insurance companies, consumers and the public sector, through a clinic and hospital network, 24/7 digital appointments and an app with around 2.7 million registered users; in Sweden it runs occupational health through its subsidiary Feelgood. In 2025 it served approximately 2.1 million individual customers and recorded around 7.2 million customer visits in Finland. FY2025 revenue was EUR 1,278.9 million (-4.6%), adjusted EBIT EUR 156.3 million (12.2% of revenue) and the result for the period EUR 92.6 million; it employs around 14,400 professionals, many of them private practitioners rather than employees. It is listed on Nasdaq Helsinki (TTALO), with OP Financial Group the largest registered holder at 13.91% at the time of the annual report.
Business units
Healthcare Services
EUR 1,031.0 million FY2025 revenue (81% of group)Integrated care paths in Finland, from preventive occupational health to primary care, specialised care, diagnostics and day surgery, sold to employers, insurers, self-paying consumers and the public sector. Occupational health customers brought EUR 588.5 million in 2025 (-2.3%), serving over 25,000 companies and approximately 722,000 people; in Q3 2026 segment revenue fell 5.8% to EUR 213.5 million. Led directly by CEO Ville Iho, with Laura Karotie as SVP, Corporate Health.
Portfolio Businesses
EUR 192.5 million FY2025 revenue (15% of group)Publicly funded outsourcing and staffing services, and consumer services including dental care and massage. Revenue fell 19.3% in 2025 as low-margin outsourcing contracts ended, while dental care grew 4.3% to EUR 52.4 million; in Q3 2026 dental care rose 54.2% to EUR 17.7 million after the Hohde Group was consolidated. Led by EVP Henri Mäenalanen; from 2027 dental becomes an Oral Health segment and staffing and outsourcing a Public Partnerships segment.
Sweden (Feelgood)
EUR 75.6 million FY2025 revenue (6% of group)Occupational health, organisational management consulting and prevention and rehabilitation of harmful use, through Sweden's second largest occupational health provider with around 21% of its market and approximately 5,000 paying corporate customers. Revenue fell 7.5% in 2025 with adjusted EBIT of EUR -2.6 million; a profit improvement programme was completed at the end of 2025. Led by EVP Stefan Kullgren.
Strategic priorities
- ARC strategy: from profitability to growth
- The ARC strategy updated in June 2026 rests on customer centricity, broad use of technology and growth, with six objectives including scaling continuous digital services and reinventing corporate health. The CFO describes the shift as moving from optimising profitability to profitable, focused growth.
- Occupational health turnaround
- A two-year occupational health development programme (to 2027) renews service models, pricing transparency and production, with more than EUR 20 million to be invested over two years. Terveystalo is growing again with large accounts and expects connected employees to grow again in Q1 2027, while SMEs still show net churn.
- Digital and AI productivity
- The Digital Health 10x ambition targets up to a tenfold productivity increase through a modular API-based platform and AI automation of clinical and administrative tasks. The Ella patient information system is rolling out in 2025-2026, AI is integrated into clinical documentation, and the Leo occupational health platform rolls out in H1.
- Retail-style packaged services
- Terveystalo is moving to transparent, fixed-price packages in orthopedics, GP and gynecology (for example an orthopedic operation at EUR 11,000) and to continuous services such as the Wellby weight management pilot with monthly pricing.
- Oral health and eye care growth
- The goal is to become a leader in oral health after the Hohde deal doubled the dental business, and to become Finland's leading eye health player through Silmäasema. From 1 January 2027 reporting segments become Healthcare Services, Oral Health, Public Partnerships and Sweden.
- New financial targets
- Adjusted EPS growth of 10% a year on average, net debt to adjusted EBITDA of no more than 3x, and at least 50% of the net result distributed, down from at least 80%.
Latest results
In Q3 2026 (July-September) revenue fell 6.2% to EUR 262.9 million and adjusted EBIT fell 33.6% to EUR 17.8 million, 6.8% of revenue (9.5%), as weak demand hit all segments; the company issued a profit warning on 20 October 2026. For January-September 2026 revenue was EUR 864.4 million (-8.9%) and adjusted EBIT EUR 77.6 million (9.0% of revenue), with net debt at EUR 647.1 million and net debt/adjusted EBITDA at 2.9 after the Hohde deal. Occupational health customer revenue fell 9.9% in Q3 on fewer connected employees, low morbidity and smaller client contracts, while insurance grew 2.4% and dental care rose 54.2%. Guidance for 2026 adjusted EBIT was cut to EUR 110-120 million (July guidance EUR 120-140 million; 2025: EUR 156.3 million), and the demand environment is expected to stay challenging in Q4.
Investments and deals
- Silmäasema acquisition
- Agreement signed 8 June 2026 to buy Finland's leading eye care and optical chain for approximately EUR 574 million (EUR 275 million cash and 36.5 million new shares), with completion expected by end-2026 or Q1 2027. Silmäasema has 155 optical stores in Finland and 10 in Estonia; synergies of EUR 11 million-EUR 15 million annual run rate are targeted.
- Hohde Group dental acquisition
- Signed 23 December 2025 at an enterprise value of approximately EUR 88 million and completed 4 September 2026 after competition approval; the combined oral health business has 1,500 dental professionals, 63 clinics and 14 laboratories, with synergies of roughly EUR 4 million.
- Solo Health Group
- Agreement signed 4 September 2026 to buy a public-sector staffing provider of physician, nursing and psychologist services with over 700 professionals and 2025 revenue of EUR 33.1 million; completion expected in H1 2027.
- Digital, IT and premises investment
- Investments excluding M&A were EUR 121.3 million in 2025, mainly right-of-use assets (premises), digital application and service development, IT systems and medical equipment. Terveystalo also took an approximately 25% stake in a joint venture that acquired a majority of Swedish AI-based health platform MedHelp Care.
- New bank financing
- EUR 550 million of bank financing was signed in Q2 2026: EUR 200 million for Hohde and refinancing and EUR 350 million conditional on the Silmäasema deal; the revolving facility was raised to EUR 100 million.
Challenges and risks
- Weak occupational health demand
- Fewer connected occupational health customers, lower employment at clients, cost-driven tendering and SME churn cut volumes; occupational health is late-cyclical, so no great improvement was expected in the second half of 2026.
- Negative operating leverage
- Lower volumes in Q3 2026 dropped through to EBIT as fixed costs could not be cut at the pace of revenue; morbidity was about 15% below the prior year.
- Public-sector savings
- Wellbeing services counties remain focused on cost savings with mostly small targeted tenders; outsourcing revenue is expected to fall by approximately EUR 25 million in 2026.
- Higher leverage and integration risk
- Net debt/adjusted EBITDA reached 2.9 against a 3x target after Hohde, with the larger Silmäasema deal still to close; the risk list includes M&A, integration and regulatory approvals.
- Staff, IT and regulatory risks
- The annual report names recruiting and retaining healthcare professionals, dependence on information systems and external providers, cyber threats, and changes from the social and healthcare reform and reimbursement systems.
What leadership says
“All in all, a disappointing quarter from Terveystalo point of view”
“We expect the number of connected employees to start growing again during the first quarter of 2027.”
“By staying put in our current service portfolio and only sort of optimizing that one our conclusion was that it's not going to yield material value creation in the future.”
“In 2025, we reinforced Terveystalo's role as a healthcare reformer.”
Where a supplier can help
- Integration of Hohde and Silmäasema
- Tied to the Hohde and Silmäasema acquisitions: roughly 70% of the Silmäasema synergies are cost synergies from network optimisation, procurement and shared digital capex, which opens room for suppliers of procurement, IT integration and network consolidation services.
- AI and digital platform delivery
- Tied to the Digital Health 10x priority and the Ella, Leo and AI documentation rollouts: vendors of clinical AI, API platforms, cybersecurity and data tools can support a company that lists IT and cyber dependence among its risks.
- Selling occupational health to SMEs
- Tied to the occupational health turnaround: SME services need repackaging to be easier to buy, use and pay for, which points to sales enablement, pricing and customer engagement tools.
- Cost control under margin pressure
- Tied to the negative operating leverage challenge and the cut 2026 guidance: offers that lower fixed costs in clinics, diagnostics or premises address a stated pain.
- Retail and subscription models
- Tied to the packaged-services priority: fixed-price packages and the Wellby monthly-priced continuous service need e-commerce, billing and consumer marketing capabilities.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like Terveystalo?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- Terveystalo Annual Report 2025
- Terveystalo is the largest private healthcare service provider in Finland by revenue and one of the leading occupational health providers in Finland and Sweden (Sweden through its subsidiary Feelgood); in 2025 it served approximately 2.1 million individual customers, had around 7.2 million customer visits in Finland, employs around 14,400 professionals and its app has around 2.7 million registered users.
- FY2025: revenue fell 4.6% to EUR 1,278.9 million (1,340.0), but adjusted EBIT rose 11.3% to EUR 156.3 million, 12.2% of revenue (10.5%); EPS rose 29% to EUR 0.73 and the Board proposed a dividend of EUR 0.64 (0.48) per share, 88% of the net result.
- Three segments: Healthcare Services (EUR 1,031.0 million revenue, adjusted EBIT 15.0%), Portfolio Businesses (EUR 192.5 million, 6.5%: outsourcing, staffing, dental, massage) and Sweden (EUR 75.6 million, adjusted EBIT EUR -2.6 million).
- Occupational health is the core: revenue from occupational health customers was EUR 588.5 million (-2.3%), serving over 25,000 companies and approximately 722,000 people; volumes fell on fewer connected customers, low respiratory infections and smaller client contracts, while insurance customers grew 4.5% to EUR 187.6 million.
- Strategy: technology-led transformation (the Ella patient information system with AI features, a "Digital Health 10x" ambition of up to a tenfold productivity increase, a MedHelp joint venture for an AI-based occupational health platform), a two-year occupational health development programme, Kela's freedom-of-choice pilot for people aged 65 and over, and market diversification (dental, public partnerships, Sweden M&A).
- M&A: signed the Hohde Group dental acquisition on 23 December 2025 (enterprise value approximately EUR 88 million), bought Silmäsairaala Pilke and Turun Silmälaser (eye care), Veikkolan Hammaslääkäriasema and Recuror, and agreed to sell the Sauma child welfare business.
- Balance sheet: net debt EUR 508.0 million, net debt/EBITDA 2.1, operating cash flow EUR 207.0 million; investments excluding M&A EUR 121.3 million, mainly digital, IT, medical equipment and premises.
- Guidance for 2026 (as published in the report): adjusted EBIT of EUR 135-165 million, with a weak first half; risks led by the availability of healthcare professionals, weak Finnish economy, IT and cyber dependence, reimbursement changes and the social and healthcare reform.
- Terveystalo Plc Interim Report January-September 2026
- Q3 2026 (July-September): revenue fell 6.2% to EUR 262.9 million (280.4); adjusted EBIT fell 33.6% to EUR 17.8 million, 6.8% of revenue (9.5%); EPS EUR 0.04 (0.13). Weak demand hit all segments and strong operational efficiency could not offset lower volumes.
- January-September 2026: revenue EUR 864.4 million (-8.9%), adjusted EBIT EUR 77.6 million (9.0% of revenue, 11.7%), net debt/adjusted EBITDA 2.9 after the Hohde deal.
- Guidance cut again: 2026 adjusted EBIT now EUR 110-120 million (July guidance EUR 120-140 million; 2025: EUR 156.3 million); the demand environment is expected to stay challenging in Q4.
- Healthcare Services Q3 revenue EUR 213.5 million (-5.8%): occupational health customers -9.9% to EUR 113.9 million on fewer connected employees, low morbidity and smaller client contracts; insurance +2.4%; the company expects occupational health end users to return to growth in Q1 2027.
- Portfolio Businesses Q3 revenue EUR 40.9 million (-9.0%): outsourcing -50.9%, staffing -6.6%, dental care +54.2% to EUR 17.7 million helped by Hohde Group, consolidated from 4 September 2026 (EUR 5.5 million in the quarter); the deal doubled the oral health business.
- ARC strategy (customer centricity, broad use of technology, growth) updated in June: agreed to buy Silmäasema (eye care, purchase price approximately EUR 574 million, closing expected end-2026 or Q1 2027) and Solo Health (public-sector staffing, 2025 revenue EUR 33.1 million); launched the Wellby weight management pilot with monthly pricing; rolling out Terveystalo Leo and Ella; AI in GP documentation.
- New medium-term targets: adjusted EPS growth of 10% a year, net debt/adjusted EBITDA no more than 3x, at least 50% of net result distributed; EUR 550 million of new bank financing; from 2027 four reporting segments (Healthcare Services, Oral Health, Public Partnerships, Sweden).
- Management: CFO Juuso Pajunen leaves on 15 December 2026; Sanna Ahonen joined as Chief Transformation Officer and Hohde founder Ville Pesonen as SVP Oral Health; Capital Markets Day postponed to spring 2027.
- Terveystalo Q3 2026 results webcast and ARC strategy update (transcript)
- CEO Ville Iho called Q3 2026 "a disappointing quarter": muted demand cut revenue roughly 6% and "the operating leverage working to negative direction"; dental was the positive.
- Occupational health is the one clear drag; Terveystalo is growing again with large accounts, still has net churn in SMEs and expects connected employees to grow again in Q1 2027. Roughly two-thirds of the connected base is large customers and one-third SMEs.
- CFO Juuso Pajunen (his final call after four years): morbidity was about 15% below last year; Q4 guidance of EUR 110-120 million adjusted EBIT assumes no material market improvement; outsourcing revenue down EUR 25 million in 2026 with one contract left.
- ARC strategy has three pillars (customer, technology, growth) and six objectives, from a "truly customer-centric healthcare services company" to scaling continuous digital services and reinventing corporate health.
- New service models: Wellby continuous-care platform starting with obesity management (full platform in Q4), packaged transparent pricing in orthopedics, GP and gynecology, Ella and a "10x" initiative to make digital appointments 10x more efficient, Leo occupational health platform rolling out in H1.
- Hohde: EV EUR 88 million, roughly 8x EBITDA with synergies, synergies roughly EUR 4 million; the combined oral health business has 1,500 dental professionals, 63 clinics and 14 laboratories; Finnish private dental market approximately EUR 700 million, expected to grow approximately 5% a year.
- From January 2027 segments become Healthcare Services, Oral Health, Public Partnerships and Sweden; Silmäasema will be its own segment; closing this year is "less and less probable".
- Net debt to adjusted EBITDA is 2.9x against the 3.0x target, with healthy covenant headroom also after Silmäasema.
- Terveystalo announces the acquisition of Silmäasema and its ARC strategy (investor call transcript)
- On 8 June 2026 Terveystalo announced the acquisition of Silmäasema, Finland's leading eye care and optical chain, together with an updated "ARC" strategy and new financial targets; CEO Ville Iho calls the combination "an outpatient powerhouse, unique in European context".
- Strategic shifts: accelerate growth and open new growth vectors; move from transactional services to "easy to use, easy to buy retail models"; focus on high-value specialist services and on digital "algorithm-led" services, leaving the generalist middle; proactive customer engagement.
- Deal: enterprise value EUR 574 million, EUR 275 million in cash plus 36.5 million new shares (around EUR 300 million at the Friday price); Coronaria becomes Terveystalo's largest shareholder; roughly 60% of shareholders already back the share issue; closing expected end of 2026 or Q1 2027.
- Silmäasema (per its CEO Teppo Lindén): 20 private and five public eye clinics or hospitals, 350 eye doctors, about 310,000 visits and operations a year, 155 optical stores in Finland and 10 in Estonia, about 360,000 glasses a year, out-of-pocket share over 90%, growth about 16% a year over six years.
- Combined: roughly EUR 1.5 billion revenue on 2025 numbers, EBITDA 20%, EBIT margin 12.5%, about two million customers; Silmäasema would be 17% of revenue and a separate segment; pro forma leverage around 2.7x.
- Synergies: EUR 11 million-EUR 15 million annual run rate, about 70% cost (network, procurement, digital capex) within 18 months and revenue synergies within three years, plus unquantified long-term cross-selling; EPS-enhancing after the first full year.
- New targets: 10% adjusted EPS growth a year, max 3.0x net debt to adjusted EBITDA, at least 50% payout (down from 80%).
- Iho on the trigger: "By staying put in our current service portfolio and only sort of optimizing that one our conclusion was that it's not going to yield material value creation in the future."
- Terveystalo sijoituskohteena (Terveystalo as an investment), Pörssisijoittajan viikko 8.9.2026
- CFO Juuso Pajunen presented Terveystalo at Pörssisijoittajan viikko on 8 September 2026 (Finnish, machine transcript; quotes below are translations): Terveystalo is "predominantly a private-money company", with Healthcare Services about 80% of group revenue almost all from occupational health, insurance and consumers.
- The summer strategy update moves the company "from optimising profitability to profitable, focused growth"; healthcare is moving towards the consumer, needing new services, transparent pricing and continuous services.
- Growth areas: Hohde (dental, closed the previous Friday, integration started) and Silmäasema (eye care, EUR 267 million revenue and 14% EBIT, awaiting competition approval); Solo Health just announced for staffing; bolt-on deals will continue.
- Fixed-price packages (e.g. an orthopedic operation at EUR 11,000) have lifted demand; a first subscription-type continuous service for a chronic condition was to be piloted within weeks; AI-assisted chat appointments.
- Occupational health has a three-part programme (commercial, operational, digital); the sales funnel is very good but large companies switch slowly; Terveystalo Leo, built on MedHelp, is being implemented at client companies; chat service giving a doctor's solution within a quarter of an hour launched.
- Pajunen admits that during the profit turnaround (EBIT % from around 5.7 to nearly 12) the company "looked too much at our own toes" and at times forgot the customer.
- Capital allocation shifted to growth: payout target cut from over 80% to 50%, leverage target 3x; occupational health is late-cyclical and no miracles are expected in H2, while consumer demand (massage, dental, healthcare) is growing.
- Healthcare Services revenue roughly EUR 1 billion: about 600 occupational health and about 200 each insurance and out-of-pocket; Finland has about 1.3 million health insurance policies.
Questions about Terveystalo
What does Terveystalo do?
Terveystalo is the largest private healthcare service provider in Finland by revenue, offering primary care, specialised care, diagnostics, occupational health, dental and wellbeing services through clinics, hospitals and digital channels. In Sweden it provides occupational health through Feelgood.
What is Terveystalo's revenue?
FY2025 revenue was EUR 1,278.9 million, down 4.6%, with adjusted EBIT of EUR 156.3 million. For January-September 2026 revenue was EUR 864.4 million (-8.9%).
How many people work at Terveystalo?
Around 14,400 professionals in 2025; at 30 September 2026 it had 8,111 employed staff and 6,268 non-employees, as most physicians are private practitioners.
What is Terveystalo's strategy?
The ARC strategy updated in June 2026 focuses on customer centricity, broad use of technology and growth, including transparent service packages, continuous digital services, an occupational health turnaround and growth in oral health and eye care through the Hohde and Silmäasema acquisitions.
Who leads Terveystalo?
Ville Iho is President and CEO. CFO Juuso Pajunen leaves on 15 December 2026; the Board is chaired by Kari Kauniskangas.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)